Replies to post #2231 on Enanta Pharmaceuticals Inc (ENTA)

[willyw]

Out of Ignorance profile picture
Out of Ignorance
Today, 10:18 AM
Contributor
Premium
Comments (4.46K)
|
@George Rho
Thanks for reading and for your interesting comment.
I appreciate your insights on its COVID therapy. I seldom discuss early stage projects in my articles, no matter how potentially transformative they may be. This goes doubly for early stage COVID therapies. There are just too many molecules with fabulous potential and intriguing clinical breadcrumbs for me to highlight any one. Every time I think something will break free from the pack, I am disappointed. Most recently Omeros' narsoplimab was my fair hair boy.
As for the reason underlying the spike last year, you sound like you have better insights on that than I do; you played it well selling at $90.